Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Phase III findings for Extina in seborrheic dermatitis to support NDA filing

April 28, 2003

Patient treatment begins in phase I trial of VIT-100

April 23, 2003

Dithiazole-based MMP inhibitors newly discovered at Shiseido

April 23, 2003

Clinical testing of Tbeta4 begins at RegeneRx

April 10, 2003

Jerini decapeptide designated orphan drug for angioedema

April 10, 2003

Infliximab effective and well tolerated in plaque psoriasis

April 10, 2003

New data on alitretinoin and bexarotene in dermatological disorders

April 10, 2003

Elidel approved in Switzerland

April 9, 2003

Prous Science announces publication of state-of-the-art review: acne vulgaris

April 8, 2003

Metvix PDT approved in Australia

April 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...